The Keller Laboratory at cc-TDI

Tuesday, August 25, 2009

Welcoming Judy !

We are excited to welcome UTHSCSA graduate student, Chi-Yun 'Judy' Chang to our laboratory for her Fall rotation. Judy graduated with a BS in Biochemistry from The University of Texas at Austin. During college, she worked in the laboratory of Dr. John T. McDevitt, developing a particle based flow cytometric assay for CA-125 for comparison with the UT Nano-Biochip system. Judy hopes to be involved in research in with cancer in the future.

Friday, August 21, 2009

Aislynn receives Guarino Award

At Convocation today, Aislynn was acknowledged as the recipient of the 2009 Armand J. Guarino Award for Academic Excellence in Master of Science Studies. As Aislynn described in her acceptance speech, her project on childhood brain tumors (medulloblastoma) was a truly multi-disciplinary endeavor. Aislynn's strong communication skills and ability to bring in collaborators across diverse disciplines made her project possible. The second of two publications from her work will be submitted this coming week. We are so proud of what Aislynn has achieved. We wish her good luck and great success in Chicago!

[ above-right: Aislynn and her parents at the awards ceremony ]

Monday, August 10, 2009

Scott Carter Foundation BIG SHOW & Golf Classic

Koichi and Charles were privileged to participate in this year's annual Scott Carter Foundation fundraiser weekend, that included the "Big Show" and the Golf Tournament at the Indian Springs Country Club in Tulsa. Scott's Family and the Foundation's many selfless volunteers make ongoing important contributions of profound impact to childhood cancer research and advocacy. We appreciate all that they do!

Friday, July 31, 2009

Welcoming Courtney !

We are excited to have a new student research assistant in our lab, Courtney Kubicek. Courtney received her first Bachelor's degree in Biomedical Science from Texas A&M in May of 2009. While at Texas A&M she was an executive officer of the safe ride program CARPOOL, which pioneered and set the standard for safe ride programs nationwide. Currently Courtney is a nursing student at the UTHSCSA, and she will work part-time assisting our PPTI program (drug testing for childhood cancers using genetically-engineered mouse models). Courtney has a long term goal of obtaining my Master's in Anesthesiology.

Thursday, July 30, 2009

Congratulations to Corrine, a TST Scholar !

Many congratulations to Corrine on being selected by the Institute for Integration of Medicine and Science as Translational Science Training (TST) Program Scholar for 2009/2010! This competitive CTSA program, and Corrine was selected as one of 6 recipients by a 16-member interdisciplinary committee. The award encompasses a stipend, travel to a national meeting and funds for research. We are all so proud of Corrine's accomplishment!

Friday, July 24, 2009

Sarcoma Awareness Fun Run/ Walk & Social a Success !

Many heartfelt thanks to Melinda Garcia and Corrine Chua for the wonderful planning that made for today's very successful "Team Sarcoma San Antonio" event. We met at Pavilion 3 in McAllister Park where we had a fun run/walk followed by a cook-out and social. “Sarcoma Knows No Borders” bracelets benefiting the Liddy Shriver Sarcoma Initiative went quickly. We were especially pleased that this year's event was well shaded and nearby a great playground for the children of participants.

For other recent Sarcoma Awareness events across Texas, click here.

To send your comments about this year's event and suggestions for next year's, feel free to email Melinda at GarciaM20@uthscsa.edu

pictured: Team Sarcoma San Antonio (TeSSA) 2009 event!

Thursday, July 23, 2009

Drug Development Conference

The Cancer Molecular Therapeutics Research Association (CMTRA) annual meeting was held at Stanford University from July 19 -22. This is an interesting intersection of academics and the pharmaceutical industry whereby confidential data presentations allow free and open intellectual exchanges about the science and implementation of drug development and clinical trials. For those interested in molecular therapeutics, this meeting is a true gem. From our lab, Jinu's work on IGF receptor inhibition was very well received.

[ pictured top right: an artwork on the Stanford campus by Auguste Rodin, entitled The Gates of Hell. After all, it was a cancer meeting. ]

You Can Participate in our Novel Therapeutics Studies !

One would like to think that tangibly better treatments for rhabdomyosarcoma, medulloblastoma and other childhood cancers can be found in a matter of years, instead of tens of years. Finding new treatments starts with research, perhaps even a new research approach to identifying effective new treatments. The Children's Cancer Therapy Development Institute focuses on finding molecules in childhood cancers that can be directly turned off or on by drugs so that the tumor stops growing. Behind our novel approach is the use of genetically-engineered mice. Our Pediatric Preclinical Testing Initiative uses mice modified from before birth so that at a certain age, and in a certain tissue, the same mutations found in a child’s cancer are activated in the mouse. These special mouse models of childhood cancer can be used to test a treatment to see whether the tumor growth and spread (metastasis) can be reversed. The specific aspect of these mice having normal immune systems is a real plus, too, because white blood cells play an important role in how tumors evolve and respond to therapy.

Our program is designed around community participation. Through the Children's Cancer Therapy Development Institute, you can contribute directly to this grass-roots initiative. Donations through small gifts or grants will assist in studying compounds that may be effective in treating such childhood cancers as alveolar rhabdomyosarcoma, embryonal rhabdomyosarcoma, or medulloblastoma (the alveolar rhabdomyosarcoma model was featured by Dr. Keller's long time collaborator and former mentor, 2007 Nobel laureate Mario Capecchi, in his Nobel Prize lecture {see 16 minutes onward}.)

For additional information regarding supporting this program please contact Charles Keller at charles@cc-tdi.org. Results obtained through these studies will be shared with the National Cancer Institute’s Cancer Therapy Evaluation Program, as well as the Children’s Oncology Group, which designs clinical trials for childhood cancer.